Show simple item record

dc.contributor.authorElgebaly, Mostafa Mahmoud
dc.date.accessioned2014-03-04T18:24:10Z
dc.date.available2014-03-04T18:24:10Z
dc.date.issued2009-12
dc.identifier.otherelgebaly_mostafa_m_200912_phd
dc.identifier.urihttp://purl.galileo.usg.edu/uga_etd/elgebaly_mostafa_m_200912_phd
dc.identifier.urihttp://hdl.handle.net/10724/26042
dc.description.abstractStatement: Admission hyperglycemia impacts ischemic stroke deleteriously but the relative role of acute hyperglycemia (HG) versus diabetes in the pathogenesis of this poor outcome is not clear. We have shown that middle cerebral artery occlusion (MCAO) causes greater hemorrhagic transformation (HT) in diabetic Goto-Kakizaki (GK) rats, a model with increased cerebrovascular matrix metalloprotease (MMP) activity and tortuosity. Objectives: 1) Determining the effect of HG on neurovascular outcomes of stroke in control versus diabetes, 2) Determining whether diabetes-induced cerebrovascular remodeling is MMP-dependant and 3) To show that prevention of vascular remodeling by glycemic control or MMP inhibition reduces HT in diabetic stroke. Methods: HG was achieved by glucose infusion before MCAO in control Wistar and mildly diabetic GK rats. Following 3 h MCAO/21 h reperfusion, we measured infarct size, HT frequency, excess hemoglobin, neurobehavioral outcome and baseline plasma and MCA MMP activity. Following chronic treatment with metformin or minocycline in a different cohort, we measured baseline cerebrovascular remodeling indices, MCA MMP activity and infarct size and HT after MCAO. Results: Infarct size was significantly smaller in diabetes. HG increased neuronal damage in diabetes but not in control. HT frequency and hemoglobin were significantly higher in diabetes. HG augmented HT in control but not in diabetes. Baseline plasma MMP-9 activity was significantly higher in diabetes. HG increased MMP-9 activity in control and diabetes. Neurological deficit was greater in diabetes. All remodeling markers including MMP-9 activity were increased in diabetes and both metformin and minocycline prevented these changes. Infarct size was smaller in minocycline-treated animals and both metformin and minocycline reduced incidence and severity of HT. Conclusions: HG worsens outcome from ischemic stroke and induces HT in control rats. A further glycemic increase in diabetes does not worsen HT suggesting baseline vascular damage. Higher basal plasma MMP-9 levels in diabetes are associated with higher HT. Since 24 h levels do not correlate with HT, earlier time points merit investigation. Diabetes-mediated stimulation of cerebrovascular MMP-9 activity promotes cerebrovascular remodeling and greater HT in diabetes. Metformin and minocycline offer vascular protection for diabetes patients who are at a 4 to 6-fold higher risk for stroke.
dc.languageeng
dc.publisheruga
dc.rightspublic
dc.subjectDiabetes
dc.subjecthyperglycemia
dc.subjectacute ischemic stroke
dc.subjectMMPs
dc.subjectMMP-9
dc.subjecthemorrhagic transformation
dc.subjectvascular protection
dc.subjectmetformin
dc.subjectminocycline.
dc.titleEffects of hyperglycemia on cerebrovascular structure, function and ischemic brain injury
dc.typeDissertation
dc.description.degreePhD
dc.description.departmentClinical and Administrative Pharmacy
dc.description.majorPharmacy
dc.description.advisorAdviye Ergul
dc.description.committeeAdviye Ergul
dc.description.committeeRandall Tackett
dc.description.committeeWilliam D. Hill
dc.description.committeeSusan Fagan
dc.description.committeeAzza El-Remessy


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record